Clinical Trials Directory

Trials / Completed

CompletedNCT01724996

Usefulness of Chest Wall Tenderness as Bedside Test to Exclude Acute Coronary Syndrome in Different Demographic Groups

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

To determine the significance of a simple bedside clinical test (chest wall tenderness) to exclude myocardial ischemia in different demographic groups.

Detailed description

When a patient is presenting with acute chest pain at the ER of the University Hospital of Zurich, the study physician in charge, who is acting simultaneously as one of four attending clinical physicians, is performing the physical examination according to routine clinical practice. The physical examination includes the testing of chest wall tenderness: Palpation of chest wall tenderness in lying 30° elevation of chest position. Flat index with standardized pressure where spontaneous maximum pain is reported (reproducible vs. not reproducible pain vs. no pain). Negative control (right side of chest mid-clavicle intercostal 6/7), reproducible vs. not reproducible pain vs. no pain. The same physician, who is blinded for the final diagnosis at the time of the physical examination, is also recording the patient history including the study interview using the standardized study questionnaire.

Conditions

Interventions

TypeNameDescription
OTHERClinical examination: chest wall tendernessThe physical examination includes the testing of chest wall tenderness: Palpation of chest wall tenderness in lying 30° elevation of chest position. Flat index with standardized pressure where spontaneous maximum pain is reported (reproducible vs. not reproducible pain vs. no pain). Negative control (right side of chest mid-clavicle intercostal 6/7), reproducible vs. not reproducible pain vs. no pain.

Timeline

Start date
2012-10-01
Primary completion
2013-11-01
Completion
2014-04-01
First posted
2012-11-12
Last updated
2014-05-28

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01724996. Inclusion in this directory is not an endorsement.